Praxis Precision Medicines, Inc. (PRAX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 12:47PM EDT. Market open.
| Previous Close | 55.16 |
| Open | 55.56 |
| Bid | 54.17 x 100 |
| Ask | 54.64 x 100 |
| Day's Range | 53.85 - 55.56 |
| 52 Week Range | 12.45 - 67.21 |
| Volume | |
| Avg. Volume | 209,088 |
| Market Cap | 928.954M |
| Beta (5Y Monthly) | 2.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Wall Street Analysts See a 144.74% Upside in Praxis Precision Medicines (PRAX): Can the Stock Really Move This High?
The consensus price target hints at a 144.7% upside potential for Praxis Precision Medicines (PRAX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Zacks
Praxis Precision Medicines (PRAX) Upgraded to Buy: Here's Why
Praxis Precision Medicines (PRAX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX) gain from positive study updates.
© 2024 Yahoo. All rights reserved.